Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Eric J. Kim, James Y. Lee, Arjun Ganga, Andrew Barton, Viren Rana, Ermias Araia, William Adriance, Rachel Wang, Ponnandai Somasundar & Leo A. Kim. (2023) Analysis of Uveal Melanoma 5-Year Survival Rates by Medicaid Status: A Nationwide Analysis. Ophthalmic Epidemiology 0:0, pages 1-7.
Read now
Read now
Dimitrios Papaconstantinou, D. Brock Hewitt, Zachary J. Brown, Dimitrios Schizas, Diamantis I. Tsilimigras & Timothy M. Pawlik. (2022) Patient stratification in hepatocellular carcinoma: impact on choice of therapy. Expert Review of Anticancer Therapy 22:3, pages 297-306.
Read now
Read now
Kangpyo Kim, Tae Hyung Kim, Tae Hyun Kim & Jinsil Seong. (2021) Efficacy of Local Therapy for Oligometastatic Hepatocellular Carcinoma: A Propensity Score Matched Analysis. Journal of Hepatocellular Carcinoma 8, pages 35-44.
Read now
Read now
Omar Abdel-Rahman. (2018) Clinical correlates and prognostic value of different metastatic sites in patients with malignant melanoma of the skin: a SEER database analysis. Journal of Dermatological Treatment 29:2, pages 176-181.
Read now
Read now
Hani Oweira, Ulf Petrausch, Daniel Helbling, Jan Schmidt, Arianeb Mehrabi, Othmar Schöb, Anwar Giryes & Omar Abdel-Rahman. (2017) Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysis. Expert Review of Gastroenterology & Hepatology 11:7, pages 695-701.
Read now
Read now
Articles from other publishers (12)
Arjun Ganga, Eric J. Kim, James Y. Lee, Owen P. Leary, Rahul A. Sastry, Jared S. Fridley, Ki-Eun Chang, Tianyi Niu, Patricia Zadnik Sullivan, Ponnandai S. Somasundar & Ziya L. Gokaslan. (2023) Disparities in Primary Spinal Osseous Malignant Bone Tumor Survival by Medicaid Status: A National Population-Based Risk Analysis. World Neurosurgery.
Crossref
Crossref
Arjun Ganga, Eric J. Kim, Gabriel L. Mintzer, William Adriance, Rachel Wang, George Cholankeril, Rajesh Balkrishnan & Ponnandai S. Somasundar. (2023) Disparities in primary pancreatic adenocarcinoma survival by Medicaid-status: A national population-based risk analysis. European Journal of Surgical Oncology 49:7, pages 1242-1249.
Crossref
Crossref
Eric J. Kim, Arjun Ganga, James Y. Lee, Roy S. Zawadzki, William Adriance, Rachel Wang, George Cholankeril & Ponnandai S. Somasundar. (2023) Disparities in hepatocellular carcinoma survival by Medicaid-status: A national population-based risk analysis. European Journal of Surgical Oncology 49:4, pages 794-801.
Crossref
Crossref
Jiachun Ding, Jiaqiang Ren, Fan Chen, Yangyang Yue, Chao Ren, Xirui Wang, Qingyong Ma, Zheng Wu & Zheng Wang. (2021) Prognostic Nomogram for pancreatic cancer with lung metastasis: a SEER database-based study. Journal of Pancreatology 4:1, pages 28-36.
Crossref
Crossref
Jincheng Feng, Ying He, Junhua Wan & Zhishui Chen. (2020) Pulmonary metastases in newly diagnosed hepatocellular carcinoma: a population-based retrospective study. HPB 22:9, pages 1295-1304.
Crossref
Crossref
Ru Wang, Yayun Zhu, Xiaoxu Liu, Xiaoqin Liao, Jianjun He & Ligang Niu. (2019) The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer. BMC Cancer 19:1.
Crossref
Crossref
Yuyou Deng, Ran Bi, Zhenhua Zhu, Shengxian Li, Bo Xu, Wakeel Rather & Chunxi Wang. (2019) A Surveillance, Epidemiology and End Results database analysis of the prognostic value of organ‑specific metastases in patients with advanced prostatic adenocarcinoma. Oncology Letters.
Crossref
Crossref
Xia Yan, Peng Wang, Zhengfeng Zhu, Zhouyu Ning, Litao Xu, Liping Zhuang, Jie Sheng & Zhiqiang Meng. (2019) Site-specific metastases of intrahepatic cholangiocarcinoma and its impact on survival: a population-based study. Future Oncology 15:18, pages 2125-2137.
Crossref
Crossref
Huaqiang Ouyang, Weidong Ma, Ti Zhang, Fang Liu, Lujun Zhao, Minghui Fang, Manman Quan & Zhanyu Pan. (2018) Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocarcinoma and synchronous liver metastases. Pancreatology 18:8, pages 983-989.
Crossref
Crossref
Omar Abdel-Rahman. (2018) Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study. Journal of Cancer Research and Clinical Oncology 144:5, pages 901-908.
Crossref
Crossref
Omar Abdel-Rahman . (2017) Clinical correlates and prognostic value of different metastatic sites in metastatic renal cell carcinoma. Future Oncology 13:22, pages 1967-1980.
Crossref
Crossref
Hani Oweira, Ulf Petrausch, Daniel Helbling, Jan Schmidt, Meinrad Mannhart, Arianeb Mehrabi, Othmar Schöb, Anwar Giryes, Michael Decker & Omar Abdel-Rahman. (2017) Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis. World Journal of Gastroenterology 23:10, pages 1872.
Crossref
Crossref